Cargando…

Antimalarial Activity of Artefenomel Against Asexual Parasites and Transmissible Gametocytes During Experimental Blood-Stage Plasmodium vivax Infection

BACKGROUND: Interventions that effectively target Plasmodium vivax are critical for the future control and elimination of malaria. We conducted a P. vivax volunteer infection study to characterize the antimalarial activity of artefenomel, a new drug candidate. METHODS: Eight healthy, malaria-naive p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collins, Katharine A, Abd-Rahman, Azrin N, Marquart, Louise, Ballard, Emma, Gobeau, Nathalie, Griffin, Paul, Chalon, Stephan, Möhrle, Jörg J, McCarthy, James S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922009/ https://www.ncbi.nlm.nih.gov/pubmed/32479608 http://dx.doi.org/10.1093/infdis/jiaa287

Ejemplares similares

A Single-Dose Combination Study with the Experimental Antimalarials Artefenomel and DSM265 To Determine Safety and Antimalarial Activity against Blood-Stage Plasmodium falciparum in Healthy Volunteers
por: McCarthy, James S., et al.
Publicado: (2019)

DSM265 at 400 Milligrams Clears Asexual Stage Parasites but Not Mature Gametocytes from the Blood of Healthy Subjects Experimentally Infected with Plasmodium falciparum
por: Collins, Katharine A., et al.
Publicado: (2019)

Population Pharmacokinetics and Pharmacodynamics of Chloroquine in a Plasmodium vivax Volunteer Infection Study
por: Abd‐Rahman, Azrin N., et al.
Publicado: (2020)

Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers
por: McCarthy, James S., et al.
Publicado: (2016)

Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
por: Phyo, Aung Pyae, et al.
Publicado: (2016)

Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum
por: Barber, Bridget E, et al.
Publicado: (2023)

A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048
por: McCarthy, James S, et al.
Publicado: (2020)

Gametocyte Dynamics and the Role of Drugs in Reducing the Transmission Potential of Plasmodium vivax
por: Douglas, Nicholas M., et al.
Publicado: (2013)

Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria
por: Woolley, Stephen D., et al.
Publicado: (2021)

Parasite-Host Dynamics throughout Antimalarial Drug Development Stages Complicate the Translation of Parasite Clearance
por: Burgert, Lydia, et al.
Publicado: (2021)

Defining the Antimalarial Activity of Cipargamin in Healthy Volunteers Experimentally Infected with Blood-Stage Plasmodium falciparum
por: McCarthy, James S., et al.
Publicado: (2021)

Assays for quantification of male and female gametocytes in human blood by qRT-PCR in the absence of pure sex-specific gametocyte standards
por: Wang, Claire Y. T., et al.
Publicado: (2020)

Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia
por: Watts, Rebecca E., et al.
Publicado: (2020)

Plasmodium vivax gametocyte infectivity in sub-microscopic infections
por: Vallejo, Andrés F., et al.
Publicado: (2016)

Plasmodium vivax Recurrence Following Falciparum and Mixed Species Malaria: Risk Factors and Effect of Antimalarial Kinetics
por: Douglas, Nicholas M., et al.
Publicado: (2011)

Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
por: McCarthy, James S, et al.
Publicado: (2017)

Viability and Infectivity of Plasmodium vivax Gametocytes in Short-Term Culture
por: Ramos, Glenda Quaresma, et al.
Publicado: (2021)

Plasmodium vivax Gametocytes Adherence to Bone Marrow Endothelial Cells
por: Salazar Alvarez, Luis Carlos, et al.
Publicado: (2021)

Antimalarial Iron Chelator, FBS0701, Shows Asexual and Gametocyte Plasmodium falciparum Activity and Single Oral Dose Cure in a Murine Malaria Model
por: Ferrer, Patricia, et al.
Publicado: (2012)

Plasmodium vivax Parasite Load Is Associated With Histopathology in Saimiri boliviensis With Findings Comparable to P vivax Pathogenesis in Humans
por: Peterson, Mariko S, et al.
Publicado: (2019)

A Pilot Randomised Trial of Induced Blood-Stage Plasmodium falciparum Infections in Healthy Volunteers for Testing Efficacy of New Antimalarial Drugs
por: McCarthy, James S., et al.
Publicado: (2011)

Piperaquine Monotherapy of Drug-Susceptible Plasmodium falciparum Infection Results in Rapid Clearance of Parasitemia but Is Followed by the Appearance of Gametocytemia
por: Pasay, Cielo J., et al.
Publicado: (2016)

Artefenomel Regioisomer RLA-3107 Is a Promising Lead for the Discovery of Next-Generation Endoperoxide Antimalarials
por: Blank, Brian R., et al.
Publicado: (2023)

Rosette formation by Plasmodium vivax gametocytes favors the infection in Anopheles aquasalis
por: Salazar Alvarez, Luis Carlos, et al.
Publicado: (2023)

Plasmodium falciparum Gametocyte Carriage Is Associated with Subsequent Plasmodium vivax Relapse after Treatment
por: Lin, Jessica T., et al.
Publicado: (2011)

Naturally acquired antibodies to gametocyte antigens are associated with reduced transmission of Plasmodium vivax gametocytes to Anopheles arabiensis mosquitoes
por: Tebeje, Surafel K., et al.
Publicado: (2023)

Liver Function Test Abnormalities in Experimental and Clinical Plasmodium vivax Infection
por: Odedra, Anand, et al.
Publicado: (2020)

Comparison of detection methods to estimate asexual Plasmodium falciparum parasite prevalence and gametocyte carriage in a community survey in Tanzania
por: Mwingira, Felista, et al.
Publicado: (2014)

Differential Effects of Antimalarial Drugs on Parasite Clearance Rates Are Reflected by Plasmodium falciparum Ring Ratio
por: Saidi, Alexuse M, et al.
Publicado: (2023)

Monoclonal Antibodies That Recognize the Alkylation Signature of Antimalarial Ozonides OZ277 (Arterolane) and OZ439 (Artefenomel)
por: Jourdan, Joëlle, et al.
Publicado: (2015)

Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048 in Healthy Volunteers
por: Sinxadi, Phumla, et al.
Publicado: (2020)

Identification of the asymptomatic Plasmodium falciparum and Plasmodium vivax gametocyte reservoir under different transmission intensities
por: Koepfli, Cristian, et al.
Publicado: (2021)

Biology and epidemiology of Plasmodium falciparum and Plasmodium vivax gametocyte carriage: Implication for malaria control and elimination
por: Alemayehu, Aklilu
Publicado: (2023)

Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion‐451840 in an induced blood stage malaria study in healthy subjects
por: Krause, Andreas, et al.
Publicado: (2016)

Retrospective Analysis Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation Offers Improvements in Efficiency of the Design of Volunteer Infection Studies for Antimalarial Drug Development
por: Andrews, Kayla Ann, et al.
Publicado: (2020)

Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development
por: McCarthy, James S., et al.
Publicado: (2016)

Application of magnetic cytosmear for the estimation of Plasmodium falciparum gametocyte density and detection of asexual stages in asymptomatic children
por: Sumari, Deborah, et al.
Publicado: (2016)

Modeling the dynamics of Plasmodium falciparum gametocytes in humans during malaria infection
por: Cao, Pengxing, et al.
Publicado: (2019)

A Plasmodium vivax experimental human infection model for evaluating efficacy of interventions
por: Collins, Katharine A., et al.
Publicado: (2020)

The molecular basis of antimalarial drug resistance in Plasmodium vivax
por: Buyon, Lucas E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i7050alni7sfb5p4c8q5f263o4